Recalls / Active ingredient / Brimonidine Tartrate

Brimonidine Tartrate

9 FDA drug recalls involving the active ingredient “Brimonidine Tartrate”.

Date	Class	Product	Firm
2026-03-05	Class II	Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manu	Apotex Corp.
2025-09-05	Class II	Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10 mL, Rx Only, Sterile, M	Apotex Corp.
2025-05-28	Class II	Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, 15 mL, Rx Only, Sterile, Manufactured by:	Apotex Corp.
2023-03-01	Class II	Brimonidine Tartrate Ophthalmic Solution 0.15%, Rx Only, Packaged as: a) 5 mL dropper bottle, NDC 60505-0564-1	Apotex Corp.
2020-06-04	Class III	Brimonidine Tartrate Opthalmic Solution 0.2%, 10 mL bottle, Rx only, Manufactured for: Somerset Therapeutics,	SOMERSET THERAPEUTICS LLC
2020-06-04	Class III	Brimonidine Tartrate Opthalmic Solution 0.2%, 5 mL bottle, Rx only, Manufactured for: Somerset Therapeutics, L	SOMERSET THERAPEUTICS LLC
2020-06-04	Class III	Brimonidine Tartrate Opthalmic Solution 0.2%, 15 mL bottle, Rx only, Manufactured for: Somerset Therapeutics,	SOMERSET THERAPEUTICS LLC
2019-03-19	Class II	Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan	Allergan Sales, LLC
2017-10-19	Class III	Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in a) 2.5 mL	Allergan Sales, LLC